Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-05-02

Clinical Trial Update: Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique [NA]

View source ↗

Summary

A clinical trial investigating insulin absorption dynamics in subclinical lipohypertrophy using an euglycemic clamp has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Graydon Meneilly | Conditions: Diabetes Mellitus, Lipohypertrophy | NA | Status: WITHDRAWN